Against all odds: The inside story of how scientists produced an Ebola vaccine

Imagine this: You have developed a vaccine against Ebola, but no one is interested in bringing it to market — there’s no money to be made. Then, there’s a large outbreak in West Africa, the whole world becomes afraid of Ebola. You do have the vaccine, but it has never been tested with humans. What now? Thanks to some outstanding reporting from STAT, a publication dedicated to life sciences by the Boston Globe Media group, you will find answers. In essence, a story of how our globalised, interconnected world works, for good and bad.